Cerner Co. (NASDAQ:CERN) insider Tracy L. Platt sold 6,948 shares of the business’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $71.38, for a total value of $495,948.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Cerner stock opened at $69.45 on Friday. The business has a 50 day moving average price of $70.10 and a two-hundred day moving average price of $70.00. The company has a quick ratio of 1.90, a current ratio of 2.04 and a debt-to-equity ratio of 0.33. The stock has a market cap of $21.14 billion, a price-to-earnings ratio of 41.84, a price-to-earnings-growth ratio of 2.23 and a beta of 0.87. Cerner Co. has a 12 month low of $53.08 and a 12 month high of $80.90.

Cerner (NASDAQ:CERN) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.61 by $0.02. Cerner had a return on equity of 18.19% and a net margin of 9.23%. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period in the prior year, the company posted $0.66 EPS. The company’s revenue was down 7.0% compared to the same quarter last year. On average, analysts expect that Cerner Co. will post 2.5 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 17th. Shareholders of record on Friday, June 5th were given a $0.18 dividend. The ex-dividend date was Thursday, June 4th. This represents a $0.72 dividend on an annualized basis and a yield of 1.04%. Cerner’s payout ratio is 29.88%.

A number of analysts have recently commented on CERN shares. UBS Group dropped their price objective on Cerner from $84.00 to $82.00 and set a “buy” rating on the stock in a research note on Wednesday, April 29th. Stephens started coverage on Cerner in a research note on Monday, July 6th. They issued an “equal weight” rating and a $75.00 price objective on the stock. Barclays dropped their price objective on Cerner from $72.00 to $67.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 29th. SVB Leerink began coverage on Cerner in a research note on Monday, April 13th. They issued an “outperform” rating and a $78.00 price objective on the stock. Finally, Royal Bank of Canada reaffirmed a “buy” rating and set a $80.00 target price on shares of Cerner in a research report on Thursday. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the stock. Cerner currently has a consensus rating of “Buy” and an average target price of $78.08.

Institutional investors and hedge funds have recently made changes to their positions in the business. Flagship Harbor Advisors LLC boosted its position in Cerner by 151.5% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 425 shares of the company’s stock valued at $29,000 after buying an additional 256 shares during the last quarter. Ellevest Inc. boosted its position in Cerner by 53.0% in the 2nd quarter. Ellevest Inc. now owns 514 shares of the company’s stock valued at $35,000 after buying an additional 178 shares during the last quarter. NewSquare Capital LLC bought a new position in Cerner in the 1st quarter valued at $38,000. Campbell Wealth Management acquired a new position in shares of Cerner in the 2nd quarter valued at $42,000. Finally, Simon Quick Advisors LLC lifted its stake in shares of Cerner by 1,440.5% in the 1st quarter. Simon Quick Advisors LLC now owns 647 shares of the company’s stock valued at $41,000 after purchasing an additional 605 shares during the period. Hedge funds and other institutional investors own 82.72% of the company’s stock.

Cerner Company Profile

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Story: What is the Current Ratio?

Insider Buying and Selling by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.